COMPLETED enrollment in our Phase 2 COVID-19 Clinical Trial

PARTNERING with BARDA in their DRIVe Solving Sepsis Initiative

Contact Us

Contact us with any questions or comments regarding our novel approach to treating infectious, inflammatory, and degenerative diseases with our plasma gelsolin technology platform.